Your browser doesn't support javascript.
loading
[Highlights of the guidelines of prevention and treatment for chronic hepatitis B (2019 version)].
Jia, J D; Hou, J L; Wei, L; Zhuang, H.
Affiliation
  • Jia JD; Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
  • Hou JL; Institute of Hepatology, Southern Medical University, Guangzhou 510515, China.
  • Wei L; Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing 102218, China.
  • Zhuang H; Department of Microbiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Zhonghua Gan Zang Bing Za Zhi ; 28(1): 21-23, 2020 Jan 20.
Article in Zh | MEDLINE | ID: mdl-32023693
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Practice Guidelines as Topic / Hepatitis B, Chronic Type of study: Guideline Limits: Humans Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2020 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Practice Guidelines as Topic / Hepatitis B, Chronic Type of study: Guideline Limits: Humans Language: Zh Journal: Zhonghua Gan Zang Bing Za Zhi Journal subject: GASTROENTEROLOGIA Year: 2020 Document type: Article Affiliation country: China Country of publication: China